Atomoxetine vs. Placebo for Daily Use

This review compared the use of a daily atomoxetine dose of 18 mg with placebo.

Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link: Access Free Full Text.

Jung Y.J., Kim A., Okamoto L.E, & Hong W.H. (2023). Effects of Atomoxetine for the Treatment of Neurogenic Orthostatic Hypotension in Patients With Alpha-synucleinopathies: A Systematic Review of Randomized Controlled Trials and a Focus-Group Discussion. Journal of Clinical Neurology (Seoul, Korea), 19(2), 165-173.

Publication 2023

Atomoxetine Placebo

Corresponding Organization :

Other organizations : Seoul St. Mary's Hospital, Daejeon St. Mary's Hospital, Catholic University of Korea, Chungbuk National University Hospital, Vanderbilt University, Chungbuk National University

Top 5 similar protocols

Variable analysis

independent variables

Daily atomoxetine dose of 18 mg

dependent variables

Measured outcomes

control variables

Placebo

Annotations

This protocol is too short. Unable to provide accurate annotations

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!